Corrigendum to “Notoginsenoside R1 alleviates cerebral ischemia/reperfusion injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway through microbiota-gut-brain axis” [Phytomedicine 128 (2024) 155530]

IF 8.3 1区医学 Q1 CHEMISTRY, MEDICINAL Phytomedicine Pub Date : 2025-06-01 Epub Date: 2025-03-19 DOI:10.1016/j.phymed.2025.156635

Shuxia Zhang , Qiuyan Chen , Meiqi Jin , Jiahui Ren , Xiao Sun , Zhixiu Zhang , Yun Luo , Xiaobo Sun

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

“三七皂苷R1通过微生物-肠-脑轴抑制TLR4/MyD88/NF-κB信号通路减轻脑缺血/再灌注损伤”[植物医学128(2024)155530]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Phytomedicine 医学-药学

CiteScore

10.30

自引率

5.10%

发文量

670

审稿时长

91 days

期刊介绍： Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.

期刊最新文献

Enhancing the efficacy of Salvia miltiorrhiza and Ligusticum chuanxiong in the treatment of coronary heart disease: The value of poorly soluble components and nanocrystal self-stabilized solid emulsions Naturally derived Erythrinin C targets γ-secretase signaling to suppress triple-negative breast cancer progression and reverse paclitaxel resistance Shenkangling alleviates renal fibrosis induced by renal ischemia–reperfusion injury by mitigating mitochondrial damage through modulation of the STING signaling pathway Targeting GRB2 with Polyphyllin H overcomes PIKFYVE inhibitor resistance in bladder cancer by blocking Akt–SREBP1–SCD1 pathway Multi-omics reveals that 4′-O-β-D-glucosyl-5-O-methylvisamminol ameliorates acute liver injury by modulating the miR-30e-3p/Tfrc axis and a multi-dimensional network of ferroptosis, inflammation, metabolism, and gut microbiota